Lineage Cell Therapeutics, Inc. Common Stock · Total Current Liabilities

Latest reported$11.37Mperiod endingDec 31, 2025

LCTX FY Current Liabilities ($200.00K → $11.37M)

Annual total current liabilities

High-resolution chart · PNG

LCTX total current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Current Liabilities (USD)
Dec 31, 2025	11,367,000
Dec 31, 2024	13,977,000
Dec 31, 2023	17,960,000
Dec 31, 2022	18,981,000
Dec 31, 2021	47,116,000
Dec 31, 2020	7,769,000
Dec 31, 2019	6,494,000
Dec 31, 2018	6,812,000
Dec 31, 2017	6,879,000
Dec 31, 2016	8,850,000
Dec 31, 2015	12,462,000
Dec 31, 2014	7,129,267
Dec 31, 2013	6,957,900
Dec 31, 2012	4,390,832
Dec 31, 2011	3,146,655
Dec 31, 2010	2,479,957
Dec 31, 2009	1,162,259
Dec 31, 2008	3,378,517
Dec 31, 2007	1,458,002
Dec 31, 2006	615,648
Dec 31, 2005	706,597
Dec 31, 2004	275,256
Dec 31, 2003	3,094,283
Dec 31, 2002	498,423
Dec 31, 2001	309,347
Dec 31, 2000	359,749
Dec 31, 1999	595,512
Dec 31, 1998	400,000
Jun 30, 1998	800,000
Jun 30, 1996	100,000
Jun 30, 1995	300,000
Jun 30, 1994	0
Jun 30, 1993	0
Jun 30, 1992	200,000